EUVIMEDEUVIMED entdecken
Crossref

Prethrombin-1 as a Drug Substance Promoting Hemostasis with Reduced Risk of Thrombosis

Johann Georg Graus, Michael Prückler, Helga Bergmeister, Christoph Mader, Alexandru Trefilov, Richard Gölles, Marianne Kunschak, Wolfgang Schramm

Thrombosis and Haemostasis · 01.01.2025 · 125 (01) · 036-045

DOI: 10.1055/s-0044-1787720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.01.2025. Verfasst von Johann Georg Graus und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biomedizinische Forschung and Bio-Produkte AG, Vienna, Austria. Hauptthemen laut MEDLINE: Hemostasis, Thrombosis, Prothrombin, Disease Models, Animal. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prethrombin-1 is a Gla-domain lacking enzymatically inactive split product that results from the cleavage of fragment 1 from prothrombin by thrombin in a feedback reaction.

Methods

A prethrombin-1 preparation derived from human plasma was tested for its hemostatic and thrombogenic properties. Animal models of nail clipping (for rabbits) and tail clipping (for mice) were developed to measure blood loss in FVIII-inhibitor or rivaroxaban anticoagulated rabbits and mice, respectively. A modified Wessler test was used in rabbits to assess the thrombogenic potential by Wessler score and clot weight. Studies were performed in groups of three to six for prethrombin-1 dose escalation and comparison with prothrombin, Beriplex®, FEIBA®, and saline as a control. Data were analyzed using t-statistics or the Mann Whitney U test as applicable.

Results

Prethrombin-1 has excellent hemostatic properties in anticoagulated mouse and rabbit bleeding models. Wessler tests suggest that in contrast to activated and nonactivated prothrombin complexes, prethrombin-1 has negligible thrombogenic potential.

Conclusion

The thrombin zymogen prethrombin-1 promotes hemostasis with reduced risk of thrombosis. Prethrombin-1 may have potential to become a life-saving treatment for patients who bleed or are at risk of bleeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemostasisThrombosisProthrombinDisease Models, AnimalAnimalsRabbitsHumansMiceHemostaticsThrombinBlood CoagulationHemorrhageMalePeptide FragmentsMice, Inbred C57BLRivaroxabanAnticoagulantsProtein Precursors

Substanzen

ProthrombinHemostaticsThrombinPeptide FragmentsRivaroxabanAnticoagulantsProtein Precursors

Autor:innen und Institutionen

  • Biomedizinische Forschung and Bio-Produkte AG, Vienna, Austria.
  • Center for Biomedical Research and Translational Surgery, Medical University of Vienna, Vienna, Austria.
  • Ludwig-Maximilians University (LMU), Department of Transfusion Medicine and Haemostaseology, Rudolf Marx Stiftung Munich, München, Germany.

Zitieren

APA

Graus, J. G., Prückler, M., Bergmeister, H., Mader, C., Trefilov, A., Gölles, R., Kunschak, M., & Schramm, W. (2025). Prethrombin-1 as a Drug Substance Promoting Hemostasis with Reduced Risk of Thrombosis. Thrombosis and Haemostasis, 125(01), 036-045. https://doi.org/10.1055/s-0044-1787720

Vancouver

Graus JG, Prückler M, Bergmeister H, Mader C, Trefilov A, Gölles R, et al. Prethrombin-1 as a Drug Substance Promoting Hemostasis with Reduced Risk of Thrombosis. Thrombosis and Haemostasis. 2025;125(01):036-045. doi:10.1055/s-0044-1787720

BibTeX
@article{Graus2025,
  author = {Graus, Johann Georg and Prückler, Michael and Bergmeister, Helga and Mader, Christoph and Trefilov, Alexandru and Gölles, Richard and Kunschak, Marianne and Schramm, Wolfgang},
  title = {Prethrombin-1 as a Drug Substance Promoting Hemostasis with Reduced Risk of Thrombosis},
  journal = {Thrombosis and Haemostasis},
  year = {2025},
  volume = {125},
  number = {01},
  pages = {036--045},
  doi = {10.1055/s-0044-1787720}
}
Kostenlos starten →